Combined analysis of phase III trials evaluating [99mTc] tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma

Vernon K. Sondak, Dennis W. King, Jonathan S. Zager, Schlomo Schneebaum, Julian Kim, Stanley P L Leong, Mark B. Faries, Bruce J. Averbook, Steve R. Martinez, Christopher A. Puleo, Jane L. Messina, Lori Christman, Anne M. Wallace

Research output: Contribution to journalArticle

78 Scopus citations

Fingerprint Dive into the research topics of 'Combined analysis of phase III trials evaluating [<sup>99m</sup>Tc] tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences